Yahoo Finance Today's Research Reports on Trending Tickers: Gilead Sciences and BeiGene
NEW YORK, NY / ACCESSWIRE / November 1, 2018 / U.S. equities rose on Wednesday as a number of high profile companies reported upbeat corporate earnings that helped boost investor confidence. The Dow Jones Industrial Average gained 0.97 percent to close at 25,115.76, while the S&P 500 Index increased 1.09 percent to close at 2,711.74. The Nasdaq Composite Index jumped 2.01 percent to close at 7,305.90.
According to Brent Schutte, chief investment strategist at Northwestern Mutual Wealth Management Company, “We’ve been trading on things that aren’t fundamental in nature, and now we’re back to looking at the fundamentals, which are very attractive.”
RDI Initiates Coverage on:
Gilead Sciences, Inc.
https://rdinvesting.com/news/?ticker=GILD
BeiGene, Ltd.
https://rdinvesting.com/news/?ticker=BGNE
Gilead Sciences' stock moved 5.36% lower Wednesday, to close the day at $68.18. The stock recorded a trading volume of 14,787,401 shares, which was above its three months average volume of 6,369,786 shares. In the last year, Gilead Sciences' shares have traded in a range of 64.27 - 89.54. The share price has gained 6.08% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $74.23 is above its 200-day moving average of $73.10. Shares of the company are trading at a Price to Earnings ratio of 40.73. Shares of Gilead Sciences have fallen roughly 11.7 percent in the past month and are down 4.83 percent year-to-date.
Access RDI's Gilead Sciences, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=GILD
On Wednesday, shares of BeiGene recorded a trading volume of 734,125 shares, which was above the three months average volume of 311,686 shares. The stock ended the day 13.78% higher at $125.94. The share price has fallen 42.78% from its 52 week high with a 52 week trading range of 77.54 - 220.10. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $145.42 is below its 200-day moving average of $167.25. Shares of BeiGene have fallen roughly 26.87 percent in the past month and are up 28.88 percent year-to-date.
Access RDI's BeiGene, Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=BGNE
Our Actionable Research on Gilead Sciences, Inc. (NASDAQ:GILD) and BeiGene, Ltd. (NASDAQ:BGNE) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
